Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Italy
Summary - Specific Contract For The Supply Of The Briumvi 150Mg Drug (Active Ingredient Ublituximab), Through The Use Of The Sintel Sda Platform.
Deadline - Apr 11, 2025
GT reference number - 106365828
Product classification - Medical equipments, pharmaceuticals and personal care products
Address - Italy
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 106365828
Document Type - Tender Notices
Description - notice_title: Specific Contract For The Supply Of The Briumvi 150Mg Drug (Active Ingredient Ublituximab), Through The Use Of The Sintel Sda Platform.local title:: Appalto specifico per la fornitura del farmaco BRIUMVI 150mg (principio attivo UBLITUXI MAB), mediante l’utilizzo della piattaforma Sintel SDA.Contract Type: : SupplyNet Budget Euro: : 75888.54Net Budget LC: : 75888.54Tender URL: : https://www.ariaspa.it/wps/portal/Aria/Home/bandi-convenzioni/e-procurement/strumenti-di-supporto/guide-e-manuali est_amount: 75888.54
Gt Ref Id - 106365828
Deadline - Apr 11, 2025
Similar Tenders :
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database